Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Italian PM's resignation will hit API sector if anti-EU party takes power says expert

Italian PM Matteo Renzi has quit after voters rejected his controversial plan for parliamentary reforms, setting the stage for political and economic turmoil.

Takeda to build €40m Irish plant for global Ninlaro API supply

Takeda will build a high containment production facility at its site in Dublin, Ireland to support the manufacturing of its oncology product Ninlaro (ixazomib).

Bluebird Bio reports positive early safety data from Ph I CAR-T trial

Bluebird Bio has reported encouraging efficacy and safety data from a Phase I trial of its CAR-T multiple myeloma therapy, bb2121.

Operator silence rings alarm bells during audits, say FDA and WHO experts

Full transparency and open conversation with operators will lead to more successful facility audits, say regulatory experts.

Spain's Idifarma adds capsule filling to service offerings

Idifarma has invested over €300,000 in its facility in Spain in order to offer its customers automated capsule filling for commercial batches.

News in brief

Ecstasy to treat PTSD by 2021? US FDA approves Ph III trial

Party drug MDMA has been claimed to be effective in helping treat Post-traumatic stress disorder (PTSD) patients, with the FDA approval for a Ph III trial to go ahead in the US.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...